Clinical Trials Browser

Phase 2 × Completed × lanreotide × Clear all

NCT02795858 2025-02-19

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Phase 2 Completed

43 enrolled 11 charts

Carcinoid Tumor

NCT00326469 2020-11-05

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

Phase 2 Completed

Neuroendocrine Tumors

NCT02698410 2020-10-01

ATLANT

Phase 2 Completed

40 enrolled 17 charts

Neuroendocrine Tumors

NCT02351128 2017-10-18

PHRC-Merkel

Phase 2 Completed

Carcinoma, Merkel Cell